Valuation: IXICO plc

Market Cap 16.97M 22.64M 20.12M 18.65M 32.02M 2.15B 32.54M 224M 87.91M 1.12B 84.97M 83.16M 3.57B P/E 2026 *
-5.54x
P/E 2027 * -5.96x
Enterprise Value 6.77M 9.03M 8.03M 7.44M 12.78M 857M 12.98M 89.45M 35.07M 447M 33.9M 33.18M 1.43B EV / Sales 2026 *
0.85x
EV / Sales 2027 * 1.21x
Free-Float
89.57%
Yield 2026 *
-
Yield 2027 * -
Current month+3.33%
1 month+3.33%
3 months-8.82%
6 months+8.77%
Current year-34.04%
1 week 7
Extreme 7
8.5
1 month 7
Extreme 7
8.5
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
13
3 years 6.26
Extreme 6.26
16
5 years 6.26
Extreme 6.26
85
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 Buy

Chairman

50,006 0.0228%
6/13/25 Free 350,000 0.3777%
6/13/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-35.42%-45.61% 22.64M
-6.60%-8.56%+49.38%+64.90% 65B
-0.31%+4.77%+8.75%+75.85% 51.2B
+0.47%-0.22%+0.22%+62.29% 51.19B
-1.53%+2.70%+30.48%+41.25% 43.93B
-1.34%+4.12%+16.64%+120.28% 41.96B
-5.97%-6.22%+228.95%+483.48% 38.14B
+6.53%+8.02%+16.40%+56.32% 33.24B
-0.90%-10.49%+37.09%+1.80% 25.2B
-0.40%+0.97%+26.40%+26.44% 22.5B
Average -1.01%-0.32%+37.89%+88.70% 37.24B
Weighted average by Cap. -1.57%-0.50%+44.34%+105.00%

Financials

2026 *2027 *
Net sales 8M 10.67M 9.49M 8.79M 15.1M 1.01B 15.34M 106M 41.44M 529M 40.05M 39.2M 1.68B 9M 12.01M 10.67M 9.89M 16.98M 1.14B 17.26M 119M 46.62M 595M 45.06M 44.1M 1.9B
Net income -2.14M -2.86M -2.54M -2.36M -4.04M -271M -4.11M -28.31M -11.1M -142M -10.73M -10.5M -451M -2.8M -3.74M -3.32M -3.08M -5.29M -355M -5.37M -37.01M -14.51M -185M -14.02M -13.73M -590M
Net Debt -10.2M -13.61M -12.1M -11.21M -19.25M -1.29B -19.56M -135M -52.84M -674M -51.07M -49.98M -2.15B -6.1M -8.14M -7.23M -6.7M -11.51M -772M -11.7M -80.59M -31.6M -403M -30.54M -29.89M -1.28B
Projected Income Statement - Annual - IXICO plc
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-10-19 GBX 7.750 0.00% 0
26-10-16 GBX 7.750 0.00% 58,391
26-10-15 GBX 7.750 0.00% 172
26-10-14 GBX 7.750 0.00% 5,999
26-10-13 GBX 7.750 0.00% 42,414
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - IXICO plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0775GBP
Average target price
0.2600GBP
Spread / Average Target
+235.48%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - IXICO plc